Panaji Journal

Arteriotomy Closure Devices Market

DelveInsight’s Arteriotomy Closure Devices Market Insights report provides the current and forecast market analysis, individual leading arteriotomy closure devices companies’ market shares, challenges, arteriotomy closure devices market drivers, barriers, and trends, and key arteriotomy closure devices companies in the market.

Key Takeaways from the Arteriotomy Closure Devices Market Report

• The arteriotomy closure devices market is projected to grow at a moderate CAGR from 2025 to 2032.

• As per DelveInsight estimates, North America is anticipated to dominate the global arteriotomy closure devices market during the forecast period.

• Notable arteriotomy closure devices companies such as Abbott Vascular, Cardiva Medical, Arstatis, Cardinal Health, St. Jude Medical, Morris Innovative Research, Scion BioMedical, and several others are currently operating in the arteriotomy closure devices market.

• In March 2025, Vasorum USA, Inc. announced FDA approval of the Celt ACD® PLUS System with Blood Signal technology. This next-gen device improves the Celt ACD® platform by offering a visual indicator for precise placement and closure, especially when ultrasound imaging is unavailable.

• In October 2024, Vivasure Medical® announced positive initial results from its U.S. IDE PATCH Pivotal Study on the Vivasure PerQseal® Closure Device System at the TCT 2024 conference in Washington, D.C. The study evaluates the safety and efficacy of this novel fully absorbable percutaneous vessel closure technology.

• In July 2024, Cordis, a global leader in interventional cardiovascular and endovascular technology, announced FDA PMA approval for its MYNX CONTROL™ VENOUS Vascular Closure Device (VCD) for procedures with access sites ranging from 6F to 12F.

To read more about the latest highlights related to the arteriotomy closure devices market, get a snapshot of the key highlights entailed in the Global Arteriotomy Closure Devices Market Report

Arteriotomy Closure Devices Overview

Arteriotomy closure devices are specialized medical tools designed to close the puncture site in an artery following catheter-based procedures such as angiography, angioplasty, or other endovascular interventions. These devices help achieve rapid hemostasis, reduce the time to ambulation, and lower the risk of vascular complications when compared to traditional manual compression methods.

They are commonly used in procedures that access the femoral artery and are especially beneficial in high-risk patients or those undergoing complex interventions. Arteriotomy closure devices are broadly categorized into active closure devices (such as clips, sutures, or plugs) and passive closure systems (including sealants and compression-based technologies).

With increasing demand for minimally invasive procedures and enhanced post-operative recovery, these devices play a critical role in modern vascular and interventional care, improving patient outcomes and procedural efficiency.

Arteriotomy Closure Devices Market Insights

North America is anticipated to lead the arteriotomy closure devices market during the forecast period, driven by the rising number of catheter-based and endovascular procedures in the region. Key factors such as favorable reimbursement policies, growing adoption of minimally invasive techniques, and continuous technological advancements in closure devices are fueling market growth. Arteriotomy closure devices play a crucial role in achieving hemostasis, reducing the time to ambulation, and minimizing complications after the procedure. Additionally, increased FDA approvals, strategic collaborations, and product innovations by leading companies are expected to strengthen the market landscape in North America further.

To know more about why North America is leading the market growth in the arteriotomy closure devices market, get a snapshot of the Arteriotomy Closure Devices Market Outlook

Arteriotomy Closure Devices Market Dynamics

The arteriotomy closure devices market is poised for steady growth, driven by the increasing volume of endovascular and interventional procedures across cardiology, radiology, and peripheral vascular specialties. These devices are essential for achieving rapid and reliable vascular closure, reducing complications, and improving patient recovery times. Rising prevalence of cardiovascular diseases, growing preference for minimally invasive techniques, and the need for quicker patient discharge are major growth drivers. While challenges such as device-related complications and high costs exist, ongoing innovations and the shift toward percutaneous procedures continue to support strong demand for arteriotomy closure solutions.

Arteriotomy Closure Devices Market Drivers:

• Rising number of endovascular and interventional procedures.

• Growing demand for minimally invasive vascular closure solutions.

Arteriotomy Closure Devices Market Barriers:

• Risk of device-related complications and failures.

• High cost of advanced closure systems limiting widespread adoption.

Get a sneak peek at the arteriotomy closure devices market dynamics @ https://www.delveinsight.com/report-store/arteriotomy-closure-devices-market

Coverage: Global

Study Period: 2022 to 2032

Key Arteriotomy Closure Devices Companies: Abbott Vascular, Cardiva Medical, Arstatis, Cardinal Health, St. Jude Medical, Morris Innovative Research, Scion BioMedical, and others.

Which MedTech key players in the arteriotomy closure devices market are set to emerge as the trendsetter, explore @ Arteriotomy Closure Devices Companies

Table of Contents

1. Electrophysiology Devices Market Report Introduction

2. Electrophysiology Devices Market Executive Summary

3. Competitive Landscape

4. Regulatory Analysis

5. Electrophysiology Devices Market Key Factors Analysis

6. Electrophysiology Devices Market Porter’s Five Forces Analysis

7. Electrophysiology Devices Market Layout

8. Electrophysiology Devices Market Company and Product Profiles

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

About DelveInsight

DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.

Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Jatin Vimal
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services